EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds

Clinical Microbiology and Infection

Volumn 14, Issue 10, 2008, Pages 982-984

  Rodriquez Tudela, J L ^a   Donnelly, J P ^b   Arendrup, M C ^b   Arikan, S ^b   Barchiesi, F ^b   Bille, J ^b   Chryssanthou, E ^b   Cuenca Estrella, M ^b   Dannaoui, E ^b   Denning, D ^b   Fegeler, W ^b   Gaustad, P ^b   Lass Florl C ^b   Moore, C ^b   Richardson, M ^b   Schmalreck, A ^b   Velegraki, J A ^b   Verweij, P ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NONE

Author keywords

Antifungal drugs; EUCAST Technical Note; Filamentous fungi; Resistance

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CONIDIUM; FUNGUS ISOLATION; GENE MUTATION; HUMAN; INCUBATION TEMPERATURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; VALIDATION PROCESS; WILD TYPE;

FUNGI;

EID: 52249111185     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02086.x     Document Type: Article

References (19)

1. Denning DW, Venkateswarlu K, Oakley KL et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-1368.
2. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL. A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 2003; 47: 1120-1124.
3. Lass-Florl C, Griff K, Mayr A et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Brit J Haematol 2005; 131: 201-207.
4. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 2004; 48: 2747-2750.
5. Mellado E, Garcia-Effron G, Buitrago MJ, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536-2538.
6. Mellado E, Garcia-Effron G, Alcazar-Fuoli L et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 2007; 51: 1897-1904.
7. Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect 2000; 41: 203-220.
8. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis - Disease spectrum, treatment practices, and outcomes. Medicine 2000; 79: 250-260.
9. Verweij PE, van den Berth MFQ, Rath PM, de Pauw BE, Voss A, Meis JFGM. Invasive aspergillosis caused by Aspergillus ustus: Case report and review. J Clin Microbiol 1999; 37: 1606-1609.
10. Rodriguez-Tudela JL, Barchiesi F, Bille J et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect 2003; 9: 467-474.
11. Aberkane A, Cuenca-Estrella M, Gomez-Lopez A et al. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother 2002; 50: 719-722.
12. Petrikkou E, Rodriguez-Tudela JL, Cuenca-Estrella M, Gomez A, Molleja A, Mellado E. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans. J Clin Microbiol 2001; 39: 1345-1347.
13. Rodriguez-Tudela JL, Chryssanthou E, Petrikkou E, Mosquera J, Denning DW, Cuenca-Estrella M. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi. J Clin Microbiol 2003; 41: 5236-5237.
14. Johnson EM, Oakley KL, Radford SA et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother 2000; 45: 85-93.
15. Odds FC, Van Gerven F, Espinel-Ingroff A et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998; 42: 282-288.
16. Rambali B, Fernandez JA, Van Nuffel L et al. Susceptibility testing of pathogenic fungi with itraconazole: A process analysis of test variables. J Antimicrob Chemother 2001; 48: 163-177.
17. Gomez-Lopez A, Garcia-Effron G, Mellado E et al. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2003; 47: 3085-3088.
18. Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 2008; 52: 2468-2472.
19. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. 2002. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.